在2型糖尿病,动脉样硬化和癌症中形成HIF驱动的巨细胞程序
Antonina Nowinka1, Gabriela Krystek1, Zuzanna Gontarek1
1Faculty of Medicine, Poznan University of Medical Sciences, 60-812 Poznań, Poland.
International journal of molecular sciences
|March 14, 2026
概括
缺氧,代谢物和外体在糖尿病,动脉样硬化和癌症等慢性疾病中重编程巨细胞. 这三位一体将氧气负债与疾病进展和免疫逃脱联系起来,提供治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 在瘤学瘤学.
- 代谢性疾病研究研究
背景情况:
- 缺氧诱导因子 (HIF) 在各种慢性疾病中对巨细胞重编程起着至关重要的作用.
- 代谢物和低氧调节的外体是这个过程中的关键调解者,影响免疫代谢和炎症.
- 这种重编程有助于2型糖尿病 (T2D),动脉样硬化和癌症的病理.
研究的目的:
- 审查T2D,动脉样硬化和癌症中缺氧-甲基-外体三位一体的机制和转化方面.
- 阐明缺氧驱动的巨细胞重编程如何影响疾病进展和免疫逃避.
- 确定与此途径相关的潜在治疗策略和生物标志物.
主要方法:
- 对2003年至2025年间发表的研究进行了集中叙事审查.
- 在PubMed,Scopus和Web of Science数据库中进行的搜索.
- 优先考虑对缺氧-HIF,乳酸/糖酸和缺氧调节的外体细胞的机制和翻译研究.
主要成果:
- 在T2D/肥胖症中缺氧促进了M1-类巨细胞,损害了伤口修复.
- 在动脉样硬化中,缺氧稳定HIF-1α,增加MMPs和削弱斑块稳定性.
- 瘤缺氧通过乳酸和糖酸盐导致免疫抑制的TAM,外体提供miR-301a-3p以增强免疫逃逸.
结论:
- 缺氧-转移代谢物-外体三位一体是氧债和疾病表型之间的关键联系.
- 治疗点包括HIF-2α,PI3Kγ,SUCNR1和基于外体的miRNA调制.
- 生物标记面板 (HIF-1α,VEGF-A,MMP-9) 可以评估缺氧负担和治疗反应.
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Psychoneuroimmunology: Diabetes and Cancer
596
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
596
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K


